Cytokine profiles and identification of novel biomarkers for treatment optimization of ulcerative colitis

Cytokine profiles and identification of novel biomarkers for treatment optimization of ulcerative colitis - Cytokine profile of ulcerative colitis

Status

Recruiting

Phases

Phase 1

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000051370

Enrollment

100

Registered

2023-06-18

Start date

2023-06-19

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ulcerative colitis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with ulcerative colitis Patients who provides the written informed consent

Exclusion criteria

Exclusion criteria: Patients who are considered inappropriate to undergo colonoscopy

Design outcomes

Primary

Measure	Time frame
Identification of mucosal and blood cytokines and biomarkers associated with therapeutic outcome	—

Secondary

Measure	Time frame
1. Pathological finding of colonoscopic biopsies associated with therapeutic outcome 2. Fecal microbiota associated with therapeutic outcome	—

Countries

Japan

Contacts

Public ContactNaoki Ohmiya

Fujita Health University School of Medicine Department of Advanced Endoscopy

nohmiya@fujita-hu.ac.jp0562939240

Outcome results